Biofilm Monitoring and Verification: What the Evidence Can and Cannot Show

Why verification is harder than it looks

Biofilm lives on surfaces; monitoring mostly samples water. Residual measurements describe the disinfectant in the water at a tap, culture describes what grew from a small volume of that water, and neither directly interrogates the pipe wall. Verification therefore rests on triangulation: operational data (residuals, temperatures, flow, turnover), microbiological data (culture, and where justified culture-independent methods), and physical evidence (inspection, coupons or sampling devices, deposits).

Each line has a blind spot. Residuals can be satisfactory at a sentinel tap while dead legs stagnate. Culture misses viable but non-culturable cells. Sequencing detects DNA from dead cells. Coupons show what grew on a coupon, not on forty-year-old iron. Good verification states which question each result answers.

What the common methods actually measure

Culture (heterotrophic plate counts, indicator organisms, Legionella and Pseudomonas culture) measures organisms that grow under the test conditions; it is the regulatory backbone and is comparable over time, but it under-reports stressed and matrix-embedded cells. ATP measurement gives a rapid total-biomass signal without identifying organisms. Flow cytometry counts cells and, with stains, distinguishes intact from damaged membranes. Quantitative PCR and 16S rRNA amplicon sequencing detect and characterise DNA; they are sensitive and reveal community composition, but DNA is not viability and sequence similarity is not species-level identification of a pathogen. Coupons and in-situ sampling devices expose a defined surface in the system so biofilm can be removed and analysed.

Inspection, whether visual, borescope or by removing fittings, remains the most direct evidence of biofilm and deposits, and should be recorded photographically.

Bulk-water testing versus pipe-surface biofilm: the 2026 Valencia study

A study published in World Journal of Microbiology and Biotechnology on 3 August 2026 (Volume 42, article 443; doi 10.1007/s11274-026-05101-x) installed in-situ biofilm sampling devices in an operational, chlorinated drinking-water distribution network in Valencia, Spain, and followed them for a year, removing biofilm every three months. Bulk water was tested by the standard methods used for compliance (faecal indicator bacteria and pathogens) together with physicochemical parameters, disinfection by-products, geosmin and metals, and both water and biofilm were characterised by 16S rRNA gene sequencing.

The headline result is the disconnect between the two matrices. No faecal indicator bacteria or pathogens were detected in any water sample across the year. Yet DNA sequencing of the biofilms, particularly those aged six and nine months, showed sequences related to potential opportunistic pathogens including Legionella spp. and Staphylococcus spp. A core community dominated by Pseudomonas spp. and Acidovorax spp. was found in both water and biofilm; the biofilm went through a clear succession with diversity peaking mid-development, and regrowth after sampling was not seasonal.

The seasonal chemistry and ecology need to be read together. Reported water-temperature measurements were 20.6 °C in June and 25.4 °C in September. Chlorine dosing was above 0.5 mg/L as Cl₂ in those warmer sampling periods, while trihalomethanes increased to a maximum of 48 µg/L and iron and manganese also rose. The network analyte was free residual chlorine. Temperature was significantly correlated with THMs, pH and metals. In the community analysis, September biofilms aligned with temperature, THMs and manganese, while June samples aligned more closely with free residual chlorine and Alphaproteobacteria. Early biofilms were richer in Acidovorax and Rhodocyclus-group organisms, while Pseudomonas, Dechloromonas and Caulobacter contributed more after three months. These co-occurring patterns are associations, not proof that temperature, residual or a particular genus caused the others.

What the Valencia study does and does not establish

It establishes that, in a real chlorinated network meeting its water-quality standards, pipe-wall biofilm carried DNA of organisms the bulk-water compliance tests did not find, and that in-situ sampling devices are a workable way to watch biofilm develop without interrupting supply. It also shows why temperature, free chlorine, DBPs, metals and community data should share one seasonal record rather than be interpreted as separate pass-or-fail indicators.

Two qualifications are essential. First, the biofilm findings are DNA detections: 16S sequences 'related to' Legionella or Staphylococcus do not prove that viable, infectious cells of a pathogenic species were present, and the study did not attempt culture or viability testing of those organisms in the biofilm. Second, the disinfectant maintained in the distribution network was chlorine. The treatment works used chlorine dioxide for primary disinfection at the plant, but final disinfection was UV and chlorination, and the network residual discussed in the paper is free chlorine. The study therefore says nothing about chlorine dioxide's performance in distribution, and nothing about any ChloroKlean product. It was one network in one Mediterranean city over one year.

Why a clear sample sheet does not mean clean pipework

The Valencia result is not an anomaly of one network; it follows from what a bulk-water sample is. A routine sample is a small volume of water, often a few hundred millilitres, taken from a particular outlet at a particular moment, and whether it is drawn first-draw or post-flush depends on the sampling purpose. Biofilm releases cells episodically, when shear changes, when a deposit sloughs or when a section is disturbed, so a single sample taken under steady conditions can easily miss a release event. Cells that do detach are often stressed by the residual and may be viable but non-culturable, so they do not grow in the standard test even when present. A negative culture therefore tells you that the sampled water, on that day, under those conditions, did not yield the target organism. It does not tell you what is on the wall of the pipe upstream.

Reading the Valencia evidence needs two separations kept in mind. The first is DNA versus viable organisms: the biofilm sequences 'related to' Legionella and Staphylococcus show that genetic material from those groups was present in the biofilm, not that infectious cells were, because sequencing does not distinguish live from dead and the study did not culture the biofilm for those pathogens. It would be as wrong to read the sequencing as proof of pathogen risk as it would be to read the negative water cultures as proof of a biofilm-free network. The second is the treatment train: the works used chlorine dioxide only for primary disinfection at the plant, with UV and chlorination as final disinfection, and the residual carried through the network was free chlorine. The bulk-water blind spot it illustrates is generic to residual-based monitoring, but nothing in the study measures how chlorine dioxide behaves as a distribution residual, and nothing in it concerns any ChloroKlean product.

The practical consequence is that a run of clear results after a disinfection intervention should be logged as one line of evidence, and that surface-based evidence (coupons, in-situ devices or inspection of removed fittings), sampling at worst-case locations under low-flow conditions, and a review of whether the system's stagnation, temperature and turnover have actually changed are what convert 'no detections' into a defensible statement that biofilm is under control.

Loose deposits: the third habitat between pipe wall and bulk water (a non-chlorinated study)

Most verification schemes treat a water system as two compartments: the bulk water that a sample bottle captures and the attached biofilm on the pipe wall that it misses. A 2026 study in npj Biofilms and Microbiomes (Timmers et al., 5 September 2026; doi 10.1038/s41522-026-01145-x) adds a third. Working in two full-scale Dutch distribution systems fed from the same surface-water source but treated differently (conventional treatment versus managed aquifer recharge and recovery, with and without ultrafiltration post-treatment), the authors sequenced 16S rRNA genes from bulk water, pipe-wall biofilm and the loose deposits, the mobile sediment that settles in low-flow sections and is resuspended when flow changes, alongside biological-stability and cultivation measurements. Loose deposits behaved differently from both other habitats: they showed stronger seasonal variation than bulk water, and during distribution they contributed an increasing share of the organisms found in the bulk water, an effect that was reduced where ultrafiltration had been added. Improved biological stability lowered regrowth potential and Aeromonas occurrence, but the treatment step and storage reshaped the community rather than simply reducing it.

The finding matters for verification because loose deposits are the habitat most likely to appear in, or vanish from, a bulk-water sample depending on hydraulics on the day. A sample taken after a period of low flow may look clean while sediment on the pipe invert carries most of the biomass; a sample taken after a flow disturbance may show a spike that reflects resuspended deposit, not new biofilm growth. Flushing that removes the deposit can change results without touching the attached biofilm at all. A verification programme that only interprets bulk-water counts, without recording flow conditions and without any deposit sampling (for example, at hydrants or drains after controlled flushing), cannot tell those situations apart.

Two limitations must be stated. First, the Dutch systems studied operate without a disinfectant residual, which is normal practice in the Netherlands but not in the UK; how chlorine, chloramine or chlorine dioxide residuals alter the balance between deposit, biofilm and bulk-water communities was not tested and cannot be inferred from this work. Second, the study describes community composition and regrowth potential, not pathogen risk or treatment efficacy. It is cited here for the structural point, that a system has three microbial habitats and a monitoring scheme should know which one it is sampling, and not as evidence about any disinfectant or any ChloroKlean product.

A proportionate verification framework

Define what 'under control' means for the system in advance, with the responsible person and in line with the relevant guidance (for UK building water systems, HSE's HSG274). Choose sentinel and representative points that include worst-case locations, not only convenient ones. Record residuals, temperatures, flow, DBPs and treatment changes on one timeline alongside microbiology so that a result can be explained. Review whether warmer conditions coincide with faster residual loss, changes in DBPs or a shift in community composition, but do not assign cause from correlation alone. Use culture for compliance and trend, and add ATP, flow cytometry, qPCR or coupons where risk, history or an unexplained result justifies them, stating in the record what each method can and cannot show. Where DNA-based results are used, say explicitly that they indicate presence of genetic material, not confirmed viable infection risk, and decide beforehand what action a positive will trigger.

Finally, treat a clean set of bulk-water results after a disinfection intervention as necessary but not sufficient. Surface evidence, trend over subsequent months and the absence of recurrence are what verify control.

Why verifying the endpoint matters: a free-chlorine gene-transfer study

A 2026 Environmental Science & Technology study (Li et al., 11 August 2026; doi 10.1021/acs.est.6c04433) gives a concrete reason to verify that a treatment reached its endpoint rather than merely disturbed the biofilm. In single- and multi-species biofilms of E. coli, Pseudomonas putida and P. aeruginosa, free chlorine at an initial 5 mg Cl/L partially disrupted biofilm structure, allowed resistant donor bacteria to colonise deeper, and significantly increased plasmid-mediated transfer of antibiotic resistance genes, with the transfer hotspot moving from the surface into the inner biofilm layer.

This is free-chlorine research and is not evidence that chlorine dioxide, or any ChloroKlean product, performs differently; chlorine dioxide was not tested. Its verification lesson applies to any oxidant: a partial-kill event can leave a biofilm that is structurally opened but not removed, so post-treatment verification should look for removal and absence of regrowth, not only a transient fall in counts.

Evidence and uncertainty

Published biofilm studies are valuable for understanding mechanisms, but their conditions may not match a particular installation. Species, surfaces, deposits and operating conditions should be recorded when interpreting evidence.

For safety-critical systems, decisions should be documented through the relevant risk assessment and management plan.

Choosing the next question

A useful next step is to identify what is known, what is inferred and what needs verification. This avoids treating a general reference as a site diagnosis.

Where a product is considered, confirm the intended use, lawful GB BPR route and label directions independently of this educational guide.

Dispersal is not elimination: a 2026 Pseudomonas mechanism study

Park and Sauer (Journal of Bacteriology, 2026) studied induced dispersion in laboratory Pseudomonas aeruginosa PAO1 biofilms. Using gene-deletion mutants, fluorescent reporters and microscopy, they tracked motility-related gene expression and the positions of the signalling protein BdlA and phosphodiesterase DipA. Dispersion-related changes appeared at the biofilm periphery: after a dispersion cue, BdlA formed clusters and relocated to the flagellated pole, where its interaction with DipA was linked to lower intracellular cyclic di-GMP and increased expression of the flagellar gene fliC. Their experiments included nitric oxide as a dispersion signal. The paper explains a transition from attached to motile cells, not clearance of a water system.

An apparent reduction in attached material is therefore not by itself proof of microbial kill. Detached cells can enter flowing water and be detected downstream or potentially attach elsewhere. For a managed system, distinguishing dispersal from removal and inactivation is a practical interpretation of this mechanism, not an outcome tested by Park and Sauer. Document the conditions under which water and surface samples were taken, including timing relative to cleaning, flow changes and flushing. Combine appropriately planned surface evidence with bulk-water trends and operational records rather than declaring the system biofilm-free from one result.

Operationally, a remediation plan should address where loosened material goes: physical cleaning and controlled flushing/removal, with safe handling of discharged water, are separate from the act of disturbing a biofilm. Where a disinfectant residual is part of the programme, verify it at representative and distal points using a method appropriate to the actual disinfectant, within the product label and written scheme. A chlorine result is not a chlorine dioxide result, and a satisfactory residual alone does not demonstrate biofilm removal. Post-treatment verification should combine water and surface evidence after the intervention and over time to check for continuing release or regrowth. These are site-management considerations, not a protocol validated by this paper.

Scope and disclosure: this was mechanistic work on P. aeruginosa in laboratory biofilms, not a field trial of pipework, a biofilm eradication protocol or a chlorine dioxide experiment. It supplies no chlorine dioxide dose, contact time, ChloroKlean product result or evidence of safe dispersal in a real system. The authors report NIH grant 1R01AI150761, state that the funders had no role in study design, collection, interpretation or publication decisions, and declare no conflict of interest.

Emerging biofilm detection technologies

Parnas and colleagues (Communications Biology, 2026) collected volatile organic compounds (VOCs) from laboratory biofilm and planktonic cultures of P. aeruginosa and Staphylococcus aureus. They recorded in vivo activity in the antennal lobe of locusts exposed to those odours, then classified patterns of neuronal activity. Biofilm and planktonic cultures produced distinguishable responses; their abstract reports classification of individual odours with up to 96% accuracy using less than five seconds of response data. This is proof-of-concept only: an experimental sensing method, not a measurement of viable cells or an established field biofilm test.

The authors note that one leave-one-trial-out analysis did not use independent training and testing data, although a separate non-overlapping trial analysis gave similar results. Biofilm and planktonic cultures could not be matched for bacterial abundance, which could affect VOC profiles. Sensor recording duration depended on locust health and surgery; all tests used in vitro cultures, not operational waterlines, mixed-species pipe biofilms or patient samples. A VOC signal does not establish the location, viability, extent or removal of a biofilm. Applying this approach to industrial or building-water monitoring would require separate validation under the relevant conditions; it cannot replace established sampling, inspection and operational controls.

Scope and disclosure: the paper did not test chlorine dioxide or ChloroKlean, and did not test treatment efficacy. The authors report NSF CAREER grant 2238686 to Debajit Saha and NSF Graduate Research Fellowships to Autumn K. McLane-Svoboda and Summer B. McLane-Svoboda; they declare no competing interests.

Use this sequence to frame investigation and control; it is not a dosing protocol.

Expert Insights

About the Reviewer

Frequently Asked Questions

Common questions about this topic, answered by our technical team.

Related Resources

Continue exploring our knowledge base and product information.